Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Martinez

Showing results (71-80 of 168) with videos related to

Pageof 17
Sort By:
The Journal of Antimicrobial Chemotherapy|September 4, 2016
Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patientsAdrian Curran, Jhon Rojas, Alfonso Cabello, et al.
AIDS Research and Human Retroviruses|November 26, 2008
Short Communication: Natural killer cells and expression of KIR receptors in chronic HIV type 1-infected patients after different strategies of structured therapy interruptionGabriel Mestre, Felipe Garcia, Esteban Martinez, et al.
Blood Advances|January 4, 2018
MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugsSilvia Maifrede, Esteban Martinez, Margaret Nieborowska-Skorska, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2008
Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumptionAgathe León, Esteban Martinez, Ana Milinkovic, et al.
Antiviral Therapy|March 1, 2012
Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO trialAdrian Curran, Esteban Martinez, Daniel Podzamczer, et al.
HIV Medicine|February 25, 2025
Impact of training healthcare professionals in the detection and management of neuropsychiatric comorbidities in people with HIV: The CONECTAR project in SpainJordi Blanch, Esteban Martinez, Álvaro Mena, et al.
AIDS (London, England)|September 7, 2006
Antiretroviral activity of didanosine in patients with different clusters of reverse transcriptase mutationsJose Luis Blanco, Alejandra Biglia, Elisa De Lazzari, et al.
AIDS (London, England)|September 27, 2005
High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovirAgathe León, Josep Mallolas, Esteban Martinez, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|May 27, 2014
The project connect health systems intervention: linking sexually experienced youth to sexual and reproductive health carePatricia J Dittus, Christine J De Rosa, Robin A Jeffries, et al.
AIDS (London, England)|August 17, 2005
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavirAnna Ochoa de Echagüen, Mireia Arnedo, Mariona Xercavins, et al.
Pageof 17

Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
The Journal of Antimicrobial Chemotherapy|September 4, 2016
Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patientsAdrian Curran, Jhon Rojas, Alfonso Cabello, et al.
AIDS Research and Human Retroviruses|November 26, 2008
Short Communication: Natural killer cells and expression of KIR receptors in chronic HIV type 1-infected patients after different strategies of structured therapy interruptionGabriel Mestre, Felipe Garcia, Esteban Martinez, et al.
Blood Advances|January 4, 2018
MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugsSilvia Maifrede, Esteban Martinez, Margaret Nieborowska-Skorska, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2008
Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumptionAgathe León, Esteban Martinez, Ana Milinkovic, et al.
Antiviral Therapy|March 1, 2012
Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO trialAdrian Curran, Esteban Martinez, Daniel Podzamczer, et al.
HIV Medicine|February 25, 2025
Impact of training healthcare professionals in the detection and management of neuropsychiatric comorbidities in people with HIV: The CONECTAR project in SpainJordi Blanch, Esteban Martinez, Álvaro Mena, et al.
AIDS (London, England)|September 7, 2006
Antiretroviral activity of didanosine in patients with different clusters of reverse transcriptase mutationsJose Luis Blanco, Alejandra Biglia, Elisa De Lazzari, et al.
AIDS (London, England)|September 27, 2005
High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovirAgathe León, Josep Mallolas, Esteban Martinez, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|May 27, 2014
The project connect health systems intervention: linking sexually experienced youth to sexual and reproductive health carePatricia J Dittus, Christine J De Rosa, Robin A Jeffries, et al.
AIDS (London, England)|August 17, 2005
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavirAnna Ochoa de Echagüen, Mireia Arnedo, Mariona Xercavins, et al.
Pageof 17